49 related articles for article (PubMed ID: 23475216)
21. Naturally processed non-canonical HLA-A*02:01 presented peptides.
Hassan C; Chabrol E; Jahn L; Kester MG; de Ru AH; Drijfhout JW; Rossjohn J; Falkenburg JH; Heemskerk MH; Gras S; van Veelen PA
J Biol Chem; 2015 Jan; 290(5):2593-603. PubMed ID: 25505266
[TBL] [Abstract][Full Text] [Related]
22. Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantation.
Zilberberg J; Feinman R; Korngold R
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1000-7. PubMed ID: 25459643
[TBL] [Abstract][Full Text] [Related]
23. Identification of minor histocompatibility antigens based on the 1000 Genomes Project.
Oostvogels R; Lokhorst HM; Minnema MC; van Elk M; van den Oudenalder K; Spierings E; Mutis T; Spaapen RM
Haematologica; 2014 Dec; 99(12):1854-9. PubMed ID: 25150256
[TBL] [Abstract][Full Text] [Related]
24. Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptides.
Granados DP; Sriranganadane D; Daouda T; Zieger A; Laumont CM; Caron-Lizotte O; Boucher G; Hardy MP; Gendron P; Côté C; Lemieux S; Thibault P; Perreault C
Nat Commun; 2014 Apr; 5():3600. PubMed ID: 24714562
[TBL] [Abstract][Full Text] [Related]
25. Identification of Biological Relevant Minor Histocompatibility Antigens within the B-lymphocyte-Derived HLA-Ligandome Using a Reverse Immunology Approach.
Hombrink P; Hassan C; Kester MG; Jahn L; Pont MJ; de Ru AH; van Bergen CA; Griffioen M; Falkenburg JH; van Veelen PA; Heemskerk MH
Clin Cancer Res; 2015 May; 21(9):2177-86. PubMed ID: 25589627
[TBL] [Abstract][Full Text] [Related]
26. Collateral damage of nonhematopoietic tissue by hematopoiesis-specific T cells results in graft-versus-host disease during an ongoing profound graft-versus-leukemia reaction.
van der Zouwen B; Kruisselbrink AB; Frederik Falkenburg JH; Jedema I
Biol Blood Marrow Transplant; 2014 Jun; 20(6):760-9. PubMed ID: 24607556
[TBL] [Abstract][Full Text] [Related]
27. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.
Pion S; Fontaine P; Desaulniers M; Jutras J; Filep JG; Perreault C
Eur J Immunol; 1997 Feb; 27(2):421-30. PubMed ID: 9045913
[TBL] [Abstract][Full Text] [Related]
28. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation.
Hobo W; Norde WJ; Schaap N; Fredrix H; Maas F; Schellens K; Falkenburg JH; Korman AJ; Olive D; van der Voort R; Dolstra H
J Immunol; 2012 Jul; 189(1):39-49. PubMed ID: 22634623
[TBL] [Abstract][Full Text] [Related]
29. Promiscuity of the AlloHLA-A2 restricted T cell repertoire hampers the generation of minor Histocompatibility antigen-specific cytotoxic T cells across HLA barriers.
Oosten LE; Blokland E; Kester MG; Falkenburg JH; van Halteren AG; Goulmy E
Biol Blood Marrow Transplant; 2007 Feb; 13(2):151-63. PubMed ID: 17241921
[TBL] [Abstract][Full Text] [Related]
30. Discovery of T cell epitopes implementing HLA-peptidomics into a reverse immunology approach.
Hombrink P; Hassan C; Kester MG; de Ru AH; van Bergen CA; Nijveen H; Drijfhout JW; Falkenburg JH; Heemskerk MH; van Veelen PA
J Immunol; 2013 Apr; 190(8):3869-77. PubMed ID: 23475216
[TBL] [Abstract][Full Text] [Related]
31. Minors come of age: Minor histocompatibility antigens and graft-versus-host disease.
Chao NJ
Biol Blood Marrow Transplant; 2004 Apr; 10(4):215-23. PubMed ID: 15077220
[TBL] [Abstract][Full Text] [Related]
32. [Identification of T cell epitopes by reverse immunogenetics].
Takiguchi M
Nihon Rinsho; 1996 Dec; 54(12):3379-88. PubMed ID: 8976124
[TBL] [Abstract][Full Text] [Related]
33. Minor histocompatibility antigens as risk factor for poor prognosis in kidney transplantation.
Pabón MA; Navarro CE; Martin R; Rodríguez M; Martin I; Gaitán L; Gómez A; Lozano E
Transplant Proc; 2011 Nov; 43(9):3319-23. PubMed ID: 22099788
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
